Free Trial
→ Here’s how you could profit from Elon’s NVIDIA partnership (From Behind the Markets) (Ad) Free NVS Stock Alerts

Novartis (NVS) SEC Filings & 10K Form

Novartis logo
$109.42 +2.11 (+1.96%)
Closing price 03:59 PM Eastern
Extended Trading
$109.76 +0.34 (+0.31%)
As of 07:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Novartis SEC Filings

Export to Excel
DateFilerForm TypeView
01/31/2025
6:07 AM		Novartis (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
01/31/2025
6:12 AM		Novartis (Filer)
Form IRANNOTICE
01/31/2025
6:14 AM		Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/31/2025
6:16 AM		Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/30/2024
5:05 AM		Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/25/2024
9:20 AM		Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/29/2024
5:20 AM		Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/18/2024
3:38 PM		Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/17/2024
4:08 PM		Novartis (Filer)
Novartis Capital CORP (Filer)
Form 424B5
09/17/2024
1:05 PM		Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/16/2024
4:12 PM		Novartis (Subject)
Form FWP
09/16/2024
7:44 AM		Novartis (Filer)
Novartis Capital CORP (Filer)
Form 424B5
09/16/2024
7:12 AM		Novartis (Filer)
Novartis Capital CORP (Filer)
Form F-3ASR
08/15/2024
3:30 PM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC 13D/A
08/13/2024
3:31 PM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC TO-T/A
08/12/2024
2:30 PM		Kowalski Robert William (Reporting)
Novartis (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/07/2024
7:12 PM		Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/07/2024
3:30 PM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC TO-T/A
08/02/2024
3:30 PM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC TO-T/A
08/01/2024
3:30 PM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC TO-T/A
07/31/2024
3:30 PM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC TO-T/A
07/30/2024
3:30 PM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC TO-T/A
07/29/2024
3:30 PM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC TO-T/A
07/25/2024
3:30 PM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC TO-T/A
07/18/2024
3:30 PM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC TO-T/A
07/18/2024
5:09 AM		Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/11/2024
3:30 PM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC TO-T/A
07/05/2024
5:02 AM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC TO-T
06/21/2024
3:30 PM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC 13D/A
06/20/2024
2:38 PM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC TO-C
06/17/2024
3:30 PM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC 13D/A
06/10/2024
3:30 PM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC 13D/A
06/04/2024
3:30 PM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC TO-T/A
05/31/2024
5:00 AM		Novartis (Filer)
Form SD
Specialized Disclosure Report  
05/22/2024
11:42 AM		Gal Aharon (Reporting)
Novartis (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/16/2024
3:31 PM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC TO-T/A
05/07/2024
3:45 PM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC TO-T/A
05/06/2024
3:30 PM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC TO-T/A
05/02/2024
3:31 PM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC TO-T/A
04/25/2024
3:30 PM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC TO-T/A
04/23/2024
5:06 AM		Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
Why Buffett and 100 members of Congress are Piling into this One Investment (Ad)

This isn't just another investment. It might be the last retirement stock you'll ever need. But this window of opportunity is closing fast.

Click here for the ticker >>>
04/18/2024
3:31 PM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC TO-T/A
04/18/2024
1:33 PM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC 13D
04/17/2024
3:30 PM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC TO-T/A
04/16/2024
4:07 PM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC TO-T/A
04/15/2024
2:44 PM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC TO-T/A
04/11/2024
5:01 AM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC TO-T
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NYSE:NVS) was last updated on 2/21/2025 by MarketBeat.com Staff
From Our Partners
Collect $7k per month from Tesla’s SECRET dividend
Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...
Investors Alley | Sponsored
Elon “obliterates” Bill Gates?
All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...
Altimetry | Sponsored
NVDA Crash Update
An overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...
Chaikin Analytics | Sponsored
Has Trump finally met his match?
Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...
Behind the Markets | Sponsored
$2 Trillion Disappears Because of Fed's Secretive New Move
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...
Stansberry Research | Sponsored
Is Starlink Set For The Largest IPO In History?
He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...
Paradigm Press | Sponsored
My 2025 AI Blueprint
I first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...
Weiss Ratings | Sponsored
Better than Bitcoin – and potentially more profitable
The world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...
Brownstone Research | Sponsored